Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:1965-1977, doi:10.1016/j.jacc.2005.08.040 (Published online 8 November 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Podgoreanu, M. V.
Right arrow Articles by Schwinn, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Podgoreanu, M. V.
Right arrow Articles by Schwinn, D. A.

New Paradigms in Cardiovascular Medicine

Emerging Technologies and Practices: Perioperative Genomics

Mihai V. Podgoreanu, MD*,* and Debra A. Schwinn, MD*,{dagger},{ddagger},§

* Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina
{dagger} Department of Pharmacology/Cancer Biology, Duke University Medical Center, Durham, North Carolina
{ddagger} Department of Surgery, Duke University Medical Center, Durham, North Carolina
§ Center for Genomic Medicine, Duke Institute for Genome Science and Policy, Durham, North Carolina.



View larger version (28K):

[in a new window]
 
Figure 1 Perioperative outcomes are complex traits, characteristically involving multiple gene-gene interactions and gene-environment interactions to produce a final clinical phenotype (presence/absence and severity of an adverse event). CPB = cardiopulmonary bypass; OR = operating room.

 


View larger version (23K):

[in a new window]
 
Figure 2 Biological systems and mechanistic pathways genetically associated with perioperative adverse events.

 


View larger version (50K):

[in a new window]
 
Figure 3 The degree of perioperative myocardial injury is a result of the balance between injurious and cardioprotective (endogenous and exogenous) biological mechanisms, mediated via a wide array of biochemical pathways with extensive genetic variability. AR = adrenergic receptor; CPB = cardiopulmonary bypass; EC = endothelial cells; PMN = polymorphonuclear neutrophils; RNS = reactive nitrogen species; ROS = reactive oxygen species.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement